logo

Biomarin Pharmaceutical Inc. (BMRN)



Trade BMRN now with
  Date
  Headline
10/8/2020 12:15:17 PM Wedbush Reiterates Biomarin Pharmaceutical Inc. (BMRN) At Outperform With $138 Price Target
10/7/2020 8:38:50 AM BioMarin Receives FDA Approval Of Label Expansion To Allow Maximum Dose Of 60 Mg For Palynziq Injection
10/2/2020 8:32:45 AM BioMarin Pharma: FDA Grants Fast Track Designation To BMN 307 For The Treatment Of Individuals With PKU
9/11/2020 8:39:38 AM BioMarin To Present Data From Phase 3, Placebo-controlled, Multicenter Trial For Vosoritide
9/8/2020 9:06:36 AM BioMarin : Vosoritide Phase 3 Data Shows Significant Increase In AGV Over 52 Weeks In Children With Achondroplasia
8/20/2020 8:34:17 AM BioMarin Submits NDA For Vosoritide To Treat Children With Achondroplasia
8/19/2020 8:03:16 AM BioMarin Receives CRL From FDA For Valoctocogene Roxaparvovec Gene Therapy For Severe Hemophilia A
8/13/2020 8:36:39 AM BioMarin Pharma: EMA Validates Marketing Authorization Application For Vosoritide To Treat Children With Achondroplasia
8/4/2020 4:13:10 PM BioMarin Q2 Loss/share $0.16 Vs. Loss $0.21 Year Ago